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Objective. To verify the relationship between vaginal pH and human papillomavirus (HPV) infection and to measure cytokine
levels in endocervical secretions of women with bacterial vaginosis (BV) or HPV. Methods. 173 women (16–48 years old) were
enrolled and divided into groups: BV, HPV, and controls. Microbiological culture and vaginal pH were measured. HPV detect by
PCR, and cytokines by ELISA (IL-2, IL-6, IL-10, IL-12, TNF-α,a n dI F N - γ cytokines). Results. Of 173 women, 60 were control
group (34.7%) and 113 were distributed in HPV (n = 36, 20.8%), BV (n = 36, 20.8%), vaginitis (n = 30, 17.3%) and, BV and
HPV-associated groups (n = 11, 6.4%). Vaginal pH > 4.5 was related with HPV infection. IL-2 and IL-12 were increased in BV
and HPV groups, and IL-6 (only BV group), compared to control group. IL-12 and IFN-γ were higher in HPV than BV group.
Conclusion. The increase of vaginal pH was associated with HPV infection; BV and HPV groups had a Th1 cytokines immune
response.
1.Introduction
The vagina and cervix are the ﬁrst lines of physical and
immunological defense against sexually transmitted patho-
gens [1, 2]. The presence of potentially pathogenic microor-
ganisms, including protozoans, yeast, bacteria, and viruses,
initiate the immune response and result in increased vaginal
secretionofimmunestimulatingmolecules,irritation,vulvar
pruritus, and a fetid odor, although in some situations it may
be asymptomatic or oligosymptomatic [1, 3].
Bacterial vaginosis (BV) of undeﬁned etiology is an in-
ﬂammatory and recurring syndrome of the lower genital
tract and is considered the most prevalent vaginal imbalance
aﬀecting women of reproductive age [4, 5]. BV is character-
ized by an alteration in the normal vaginal ﬂora, in which
the predominant lactobacilli are replaced by various other
microorganisms. Increases in species such as Gardnerella
vaginalis, Mobiluncus spp., Bacteroides sp., Prevotella spp.,
Peptostreptococcus spp., Mycoplasma hominis,o rUreaplasma
urealyticum are routinely detected and are accompanied by
a subsequent increase in the vaginal pH [5, 6]. Bacterially
produced proteases degrade the mucus secreted from the
cervix to facilitate the pathogen’s ability to contact and
breach the protective epithelial barrier [2].
Thehumanpapillomavirus(HPV)isasexuallytransmit-
ted DNA virus and is the main causative agent of cervical
tumors [7]. Distinct proﬁles of microorganisms colonizing
the vagina have been associated with the development of cer-
vical intraepithelial neoplasia (CIN) and HPV infection [8–
10].HPVprevalencehasbeenestimatedat27.4%worldwide,2 ISRN Obstetrics and Gynecology
and the frequency of women infected by at least one of the
oncogenic types has been shown to be signiﬁcantly higher
than that with only low-risk types (18.7% versus 7.5%) [11].
The physiological defense mechanisms targeting foreign
microorganisms, such as viruses or bacteria, are mediated
by the innate and adaptive immune responses [12]. The
eﬀector phases of both innate and adaptive immunity are
often regulated by peptide molecules known as cytokines
[2]. In innate immunity eﬀector cytokines are produced
by mononuclear phagocytes and epithelial cells, while in
adaptive immunity they are produced by activated T lym-
phocytesthatarecapableofinducinginﬂammatoryreactions
[13,14].Manyofthesecytokines,knownasinterleukins(IL),
are produced by certain populations of leukocytes residing
in the bloodstream, including monocytes, neutrophils, or
eosinophils [12, 15]. The pattern of immune response can be
divided into Th1, Th2, and Treg, these three patterns are best
known; however, others as the Th-17 have been described
[16]. Increase in the levels of IL-10 from T lymphocytes in
culturesupportsthehypothesisthattheimmunosuppression
of Th2 cytokines may promote the development of cervical
lesions [17].
Understanding the mechanisms mediating the infectious
and inﬂammatory processes that occur in the vaginal region
will contribute to our understanding of the pathogenesis
of these infections. We chose to examine the localized
cytokines IL-2, IL-12, TNF-α,a n dI F N - γ because they
are representative of a type 1 T-helper lymphocyte (Th1)
response that regulates cytotoxic T lymphocytes, which are
in part responsible for clearing infections in the genital tract,
inassociationwithphagocyticcellsandsolubleantimicrobial
factors. Additionally, the cytokines IL-6 and IL-10 were cho-
sen because IL-6 function is an anti-inﬂammatory molecule
and IL-10 is a general regulatory cytokine. According to
previousstudiesthereisarelationshipbetweenthatvirusand
increasedvaginalpH[6]. Therefore,ourobjectives aretover-
ify the relationship between vaginal pH and HPV infection
and to measure cytokine levels in endocervical secretions of
women with BV or HPV.
2.MaterialsandMethods
2.1. Subjects. After approval by the Committee of Ethics for
Human and Animal Research of the Goi´ as Anticancer Asso-
ciation (ACCG), the work was initiated. From April 2007 to
February 2008, a total of 173 women between the ages of
16 and 48 years were prospectively enrolled; this age range
was chosen because it usually corresponds with the more
sexually active years for women. Initially, study participants
wererecruitedfromtheGynecologyandBreastServiceofthe
ACCG, but our enrollment was extended to the Basic Health
Units located in distinct regions of the city of Goiˆ ania, GO,
Brazil.
The necessary sample size for this particular age group of
women was estimated by considering the known prevalence
of bacterial vaginosis (25%) [5] and vaginal HPV infection
(15%) [5, 8, 18]. Based on this calculation and desired test
power >80%, the study required 157 women; we further
took into account a 10% potential loss to followup and
determinedthatatotalof173participantsshouldbeenrolled
in the research study. The women were divided into BV and
HPV groups and healthy controls. The control group will
be selected according to Gram staining showing exclusive
presence of lactobacilli, along with negative cultures for
other microorganisms and clinical features compatible with
normality.
2.2. Sample Collection and Preparation for Analysis. After
each participant gave written informed consent, biological
material was collected from the posterior fornix by using
a gynecological brush [17]. The sample was immediately
inoculated onto Columbia-CNA (colistin—nalidixic acid)
agar with 5% human blood and into tubes with BHI-PRAS
broth that had been prereduced, anaerobically sterilized, and
supplemented with hemin, vitamin K, and yeast extract. The
plates and tubes were immediately placed in an anaerobic jar
and transported to the laboratory for processing as described
[8]. We also measured the individual’s vaginal pH (posterior
cul-de-sac), performed an amine test [5], and prepared
histological slides for a Pap smear and a Gram stain.
Diagnosis of bacterial vaginosis was made when three
of the four established clinical criteria were met: vaginal
discharge, pH > 4.5, positive amine test, and the presence
of clue cells [4]. Presumptive identiﬁcation was made when
typical bacterial small colony morphology was observed and
beta hemolysis was detected upon incubation at 35◦Cf o r
up to 72 hours in an atmosphere of 5–7% CO2. In those
cases, diagnosis was conﬁrmed by tests of carbohydrate
fermentation, motility, and rapid hippurate hydrolysis [17].
The sample that had been collected from the endocervix
was used for laboratory measurement of cytokine levels
and the presence of high-risk and low-risk HPV. The tube
containing the endocervical secretion was centrifuged and
saline (0.85%) was added to obtain a ﬁnal volume of 500μL,
which was then aliquoted and stored at −70◦C until use
for cytokine measurement by ELISA. The cultured plate
was used for microbiological analysis after 48–72 hours of
incubation at 37.0 ±0.5◦C.
2.3. Cytokine Detection by Enzyme-Linked Immunosorbent
Assay (ELISA). For cytokine measurement, an aliquot of the
endocervical secretion was thawed and subjected to ELISA
using pairs of commercially available monoclonal antibodies
(BD Biosciences, Franklin Lakes, NJ, USA). All cytokines
were standardized in a concentration of 10ng/mL, except
for that for TNF-α which was standardized at 100ng/mL.
The ELISAs for the samples and controls were performed
in duplicate at the Oncology Research Institute of Federal
University of Triˆ angulo Mineiro—UFTM. Standard recom-
binant cytokines were used as controls. Samples previously
diluted in saline were further serially diluted with assay
diluent (PBS and fetal bovine serum), according to the BD
recommendations. The spectrophotometric absorbance at
405 and 490nm was measured and the diﬀerence of the
valueswasmultipliedbythedilutionfactoroftheinitialdilu-
tion of the samples in saline. The concentration of cytokines
was determined in pg/mL by comparing the absorbancesISRN Obstetrics and Gynecology 3
withthoseofastandardcurvefortherespectiverecombinant
cytokine [19].
2.4. DNA Extraction and Polymerase Chain Reaction (PCR).
We diluted 100μL of the initial 500μLs a m p l ei nT R I z o lt o
extract DNA, according to the manufacturer’s instructions
(Invitrogen, Carlsbad, CA, USA). We performed PCR to
test for the presence of low-risk HPV 6 and 11 (40 cycles)
and high-risk HPV 16, 18, 31, 33, and 35 (35 cycles)
using the primers 5  to 3  TACACTGCTGGACAACATGC
and 5  to 3  GTGCGCAGATGGGACACAC, for the low-
risk strains, and 5  to 3  TTTGTTACTGTGGTAGATACTAC
and 5  to 3  GAAAAATAAACTGTAAATCATATTC for the
high-risk strains, as previously described [18, 20]. The
ampliﬁed products were mixed with 5μLo fs a m p l eb u ﬀer
and electrophoresed through a polyacrylamide gel (10%) at
90 volts for 2 hours and stained with 2% silver nitrate. A
standard 50bp molecular weight marker was used on each
gel (Trackit 50bp DNA ladder, Invitrogen). The gel was then
analyzed for the presence of speciﬁc banding patterns [21].
2.5. Statistical Analysis. Descriptive statistical analyses were
carried out, including examination of the frequency distri-
butions of categorical data. The prevalence was calculated to
reﬂect the relative frequency of genital infections using con-
ﬁdence intervals (CIs) and odds ratios. The chi-squared and
Mann-Whitney tests were used to determine if diﬀerences
among the groups reached statistical signiﬁcance (P<0.05).
3. Results
The women were divided into three groups according
to presence of BV, high- and low-risk HPV infection or
noninfected healthy controls (see Table 1). Of a total of 173
women enrolled in the study, 60 (34.7%) belonged to the
control group and 113 had the following division: HPV (n =
36, 20.8%), BV (n = 36, 20.8%), vaginitis (n = 30, 17.3%),
and BV and HPV-associated were in (n = 11, 6.4%). Of the
47 patients infected with HPV, 36 were only by this virus and
11 were associated with BV. Among those infected only with
HPV 19 (52.8%) had only high-risk HPV, 12 (33.3%) the
low-risk, and 5 (13.9%) had both subtypes. Coincidentally,
thesamenumberofpatientswasdiagnosedwithBV(47)and
36 (76.6%) had only this disease, 6 (12.8%) were associated
with high-risk HPV, 4 (8.5%) associated with HPV low-risk,
andonlyoneofthemhadbothBVandviraltypes.Inwomen
with BV, 41 (87.2%) were associated with the presence of
Gardnerella vaginalis and 6 with other anaerobic bacteria.
The diagnosis of BV was made in 47 cases when three of
the four routine clinical criteria were detected. In particular,
pap smear analysis revealed clue cells in 41 of the cases.
However, Gram staining was positive in 95.8% of the 47
diagnosed BV patients.
The women were divided into groups based on their
clinicalandmicrobiologicalcharacteristics.Thenormalﬂora
in the control group was found to consist of Lactobacillus
sp. and other bacilli and Gram-positive cocci. The 47 BV-
positive cases harbored Gardnerella vaginalis (GV; in 87.2%),
Prevotella sp. (in 42.5%), and Clostridium sp. (in 14.9%),
in addition to other anaerobes. Among the 41 cases of
GV diagnosed by culture, 11 also had HPV (26.8%; P =
0.373), and six of these 11 were of high risk (P = 0.850),
four were of HPV low-risk (P = 0.616), and one had
both low and high-risk strains (P = 0.200). In the group
without GV, we observed a similar rate of HPV infection
(36 cases; P = 0.787). The same comparisons were made
for the group with and without increased anaerobic bacterial
ﬂora. Forty-three (27.0%) of the women who presented
with the prevalent of anaerobic had HPV, which was similar
to those in which we did not identify any prevalence of
anaerobes (28.6%) (P = 0.902). There was not observed an
association between the presence of HPV and the presence
of predominant anaerobic bacteria however, we identiﬁed a
statistical association between vaginal pH > 4.5 and HPV
infection (Table 1).
LevelsofthecytokinesIL-2,IL-6,IL-12,IFN-γ,andTNF-
α were measured in the presence of BV and HPV-infected
women, and they were compared with their corresponding
concentrations for the healthy control group. Only IL-
2, IL-6, IL-10, and IL-12 levels were statistically diﬀerent
from controls; however IL-10, TNF-α,a n dI F N - γ were not
(Table 2). The association between HPV and BV occurred
in 11 patients with IL-12 of 143.00pg/mL, a statistically
signiﬁcant diﬀerence when compared to the control group
44,30pg/mL, P = 0.04. The association between high- and
low-riskHPV(n = 6),BVandlow-riskHPV(n = 4),BVand
high-riskHPV(n = 6),andVBandhigh-lowrisksHPV(n =
1) could not be statistically determined due to the relatively
low numbers of patients. The other cytokine concentrations
and the association between bacterial vaginosis (BV), HPV,
high-risk HPV, and low-risk HPV are in Table 2.
4. Discussion
Inthisstudy,ourcohortexhibitedincidencesofBVandHPV
that were higher than those previously reported [5]. This
ﬁnding may be due to the fact that our collection strategy
included women presenting at the Basic Health Units, which
are the ﬁrst place women come with primary health care
concerns and by patients of tertiary care services.
Papanicolaou smears are a routine method used to
identify the presence of clue cells associated with BV [8, 22].
We performed this type of diagnostic analysis, but found
that the Gram stain method was much more sensitive for
detecting BV [5, 23]. Furthermore, we identiﬁed Gardnerella
vaginalis as the main microorganism associated with the
appearance of BV in our study cohort. These particular
results are consistent with other previous studies [3, 5, 24].
The fact that some patients do not have vaginal pH > 4.5
does not exclude them from the group with BV [4].
Changes in the vaginal ﬂora, such as the appearance of
clue cells, suggest that BV occurs with a signiﬁcantly higher
frequency in women with cervical cytological abnormalities.
A higher frequency of HPV has also been observed in these
patients and is presumed to be supported by the production
of nitrosamines by anaerobic bacteria and subsequent stim-
ulation of cytokine production [18]. However, in our study,4 ISRN Obstetrics and Gynecology
Table 1: Association between BV, HPV, HR HPV, and LR HPV and vaginal pH >4.5.
pH > 4.5 pH ≤ 4.5 OR CI P
N % N %
Only HPV 23 63.9 13 36.1 2.25 1.066–1.887 0.031
Only BV 26 72.2 10 27.8 3.05 1.196–2.062 0.005
BV and HPV 11 100.0 0 0.0 24.76 1.770–2.437 <0.001
BV and HR HPV 6 100.0 0 0.0 13.16 1.727–2.344 0.029
BV and LR HPV 4 100.0 0 0.0 13.16 1.727–2.344 0.029
BV and HR and LR HPV 1 100.0 0 0.0 2.86 1.689–2.262 0.330
Control group 19 31.7 41 68.3 0.28 0.343–0.762 <0.001
BV: bacterial vaginosis, HPV: human papillomavirus, n: number of cases, OR: odds ratio, CI: conﬁdence interval of 95%, HR: high risk, LR: low risk.
we did not ﬁnd an association between HPV infection and
the presence of Gardnerella vaginalis (P = 0.890), Prevotella
sp. (P = 0.150), or any other species of anaerobic bacteria
(P = 0.840) in the vaginal mucosa and conclude that the
predominance of anaerobic microorganisms in vaginal ﬂora
was not signiﬁcantly associated with the appearance of HPV
infections.
Considering that BV, cervicitis, and CIN have been
associated in some studies, it would not be surprising if the
patients with BV and CIN presented with similar proﬁles
in their localized immune response [17]. In contrast, our
patient cohort did not exhibit a signiﬁcant association bet-
ween the presence of HPV and bacterial vaginosis.
One of the most common recognized factors among
women with BV is the elevation of the vaginal pH [5]. Murta
et al. (2007) measured the vaginal and the endocervical pH
usingadigitalpHmeterandconcludedthatendocervicalpH
was 5, 4 and it was diﬀerent from posterior vaginal fornix
with pH =4.9 [25]. Accordingly, we found a statistically
signiﬁcant association between pH and HPV in this study,
where women with a pH >4.5 in posterior vaginal fornix
(mean = 5.4) were predisposed to the appearance of HPV
infections (P = 0.031) [18, 26]. Moreover, we believe that
increased vaginal pH may be common in infections due to
HPV and independent of the presence of BV. Another study
concluded that BV was more common among women with
high-grade squamous intraepithelial lesions (SIL) than in
womenwithnocytologicalabnormalities,butfurtherstudies
are required to conﬁrm this hypothesis [27]. Knowing the
environment that favors the appearance of the viral infection
is possible to understand the pathogenesis of this viral
infection and seek alternative prophylaxis.
Sampling the endocervical secretion is a reliable, highly
reproducible method to detect cytokine concentrations in
the genital tract [2]. By this method, we observed increased
concentration of IL-10 in the presence of genital HPV
infections and particularly in cases of infections with only
high-risk HPV. The levels of IL-12 were likewise signiﬁcantly
higher in patients with HPV and only HPV infections
compared to control and only BV groups. Findings by
other authors have indicated a correlation between the
concentrationsofIL-10andIL-12andpreviouscervicalHPV
infection or infection with other pathogenic agents, such as
HIV, which can compromise the integrity of the epithelial
barrier and lead to accumulation of serum proteins in the
cervix [28]. However, a study by Gravitt and colleagues
determined that this association of an increase in IL-12 only
occurred when there was a coinfection with HIV and HPV
[29].
The local production of cytokines in cervix is important
for the regulation of immunity in the genital tract [27].
Researchers have reported that an increase in IL-12 was
present in women with increased vaginal pH, a characteristic
of women with BV compared to health women [16, 29], and
we also found statistically signiﬁcant values. In our study, we
found that increased IL-12 was associated with BV patients
co-infected with HPV strains (P = 0.039), but not those who
have coinfection with high-risk HPV strains (P = 0.256).
The levels of IL-2 are not increased in patients with
HPV, HIV, or other STDs, probably because this cytokine
is produced very early in the immune process and rapidly
degraded [13]. However, we observed a signiﬁcant increase
of this cytokine in the presence of BV, total HPV, and high-
risk HPV, demonstrating that the collection was carried out
eﬀectivelyanddoseobtainedbeforeapossibledegradationof
IL-2, and we could also identify an increase of this cytokine
in association of BV and HPV infections compared to BV
group. Cytokines of the Th1-type (IL-2, 6, 12) enhance cell-
mediated immune responses, whereas cytokines of the Th2-
type (IL-4, 5, 10) inhibit it [12]. Tang et al. (2008) ﬁnd that
IL-2 deﬁciency contributes to intraislet Treg cell dysfunction
and progressive breakdown of peripheral self-tolerance in
the nonobese diabetic (NOD) mouse and Il-2 was originally
discoveredasaT-cellgrowthfactorandactivatorofcytotoxic
lymphocytes in inﬂammatory settings such as microbial
infection [30]. Studies indicate an increase in IL-2 as an
indicator of eﬀective immune response during activation
and proliferation of lymphocytes and their reduction as an
immunosuppression factor.
These cytokines IL-6 and IL-8 are probably associated
with the development of cervical cell lesions [17, 31]. These
same authors also reported signiﬁcant increases in IL-6, IL-
8, and IL-10 in women with BV. In our study, we observed
a signiﬁcant increase in the levels of IL-6 in women with BV,
butnotinassociationwithBVandcoinfectionwithHPV.We
also observed a tendency to increase IL-10 levels in patients
with HPV occurred simultaneously with other infections.
Cytokines of the Th1-type (IL-2, 6, 12) could enhanceISRN Obstetrics and Gynecology 5
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cell-mediated immune responses, like those probably seen
in BV [12]. The literature also provides evidence that
increases in IL-10 occur in lymphocytic inﬁltrates that
correspond to HPV infections and are related to the Th2-
type response. Likewise, increasing pH is a characteristic of
immune responses and elevation of pH is considered to be a
predisposing factor for HPV infection [29].
In this study, the levels of IFN-γ in women with HPV
exceptinlow-riskHPVwereratherabovethoseofthecontrol
group. According to a previous study, the presence of HPV
associated with the regression of cervical lesions may be the
result of a Th1 response (decreased IL-8 and increased IFN-
γ). Although one study reported a decrease of IFN-γ during
HPV infections [17], our study show a signiﬁcant increase
of this cytokine in the presence of HPV infection or BV
compared to health women, although when this cytokine
was evaluated in only HPV infections or only BV group, its
became lower than control group. We could relate that the
isolated presence of these complications would decrease the
Th1 response. This ﬁnding may be related to other factors
that were not evaluated in our study, such as hemoglobin
contamination, volume of secretion, or day of menstrual
cycle [29].
The increases in TNF-α have not been reported as signif-
icantly diﬀerent between BV-positive and -negative subjects
[32]. Due to the instability of this cytokine in ambient
temperatures, we measured it ﬁrst, as suggested by Sturm-
Ramirez et al. (2000) [4]. Previous studies have identiﬁed a
localized increase in cytokines in the presence of anaerobic
bacteria, such as Gardnerella sp. and Prevotella sp., having
aN u g e n ts c o r e>4 when compared to a group with an
abundance of Lactobacillus sp. [32]. An increase in TNF-α
and leukocytes in BV-diagnosed women with GV has also
been reported [4]. We need to point out, however, that we
did not observe a relationship between high levels of TNF-α
and the presence of BV or in association with BV and HPV
infections. Further studies are needed to conﬁrm the lack of
change in TNF-α for cases of HPV infections and BV. Other
vaginal infections also are inﬂuenced by the concentration of
cytokines. In candidiasis, increases in IL-10 and decreases in
IFN-γ havebeenreported[33].Trichomoniasisappearstobe
associated with high levels of IL-10 and IL-12 [13]; however,
that particular study was focused only on HPV infection in
the presence of BV as reported in recent study [34].
Unfortunately, it wasnot possible to eliminate the natural
variations in cytokine concentrations that occur during
diﬀerent phases of the menstrual cycle because the samples
were collected at diﬀerent times of the cycle, and it was
diﬃcult to accuratelydetermine the duration of the infection
for the individuals included in our study. Stages of infection
can also inﬂuence the diﬀerent cytokine levels and the
secreted cytokine proﬁle can inﬂuence the outcome of an
infection. A cohort in order to control these factors could
contribute for analyzing those variables.
We conclude elevation of vaginal pH (>4.5) was frequent
in genital HPV infections. We also found IL-2 and IL-12
was increased in individuals with BV and HPV infections,
whereas individuals with only BV had higher cytokine levels
of IL-2, IL-12, and IL-6, compared to control group, the
cytokines IL-12 and IFN-γ were higher in HPV group than
only BV. By comparing the levels of cytokines in vaginal
secretion among high-risk HPV, low-risk HPV, and BV
groups, we found that a Th1 immunological response was
occurring.
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